Bell JC - Search Results

1

Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.

Taha Z, Crupi MJF, Alluqmani N, MacKenzie D, Vallati S, Whelan JT, Fareez F, Alwithenani A, Petryk J, Chen A, Spinelli MM, Ng K, Sobh J, de Souza CT, Bharadwa PR, Lee TKH, Thomas DA, Huang BZ, Kassas O, Poutou J, Gilchrist VH, Boulton S, Thomson M, Marius R, Hooshyar M, McComb S, Arulanandam R, Ilkow CS, Bell JC, Diallo JS. Taha Z, et al. Among authors: bell jc. Nat Commun. 2024 Aug 23;15(1):7267. doi: 10.1038/s41467-024-51498-0. Nat Commun. 2024. PMID: 39179564 Free PMC article.

2

Cell adhesion properties of myelin-associated glycoprotein in L cell fibroblasts.

Afar DE, Marius RM, Salzer JL, Stanners CP, Braun PE, Bell JC. Afar DE, et al. Among authors: bell jc. J Neurosci Res. 1991 Aug;29(4):429-36. doi: 10.1002/jnr.490290403. J Neurosci Res. 1991. PMID: 1724267

3

Alternative splicing of STY, a nuclear dual specificity kinase.

Duncan PI, Howell BW, Marius RM, Drmanic S, Douville EM, Bell JC. Duncan PI, et al. Among authors: bell jc. J Biol Chem. 1995 Sep 15;270(37):21524-31. doi: 10.1074/jbc.270.37.21524. J Biol Chem. 1995. PMID: 7665564 Free article.

4

In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.

Duncan PI, Stojdl DF, Marius RM, Bell JC. Duncan PI, et al. Among authors: bell jc. Mol Cell Biol. 1997 Oct;17(10):5996-6001. doi: 10.1128/MCB.17.10.5996. Mol Cell Biol. 1997. PMID: 9315658 Free PMC article.

5

The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing.

Duncan PI, Stojdl DF, Marius RM, Scheit KH, Bell JC. Duncan PI, et al. Among authors: bell jc. Exp Cell Res. 1998 Jun 15;241(2):300-8. doi: 10.1006/excr.1998.4083. Exp Cell Res. 1998. PMID: 9637771

6

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC. Stojdl DF, et al. Among authors: bell jc. Nat Med. 2000 Jul;6(7):821-5. doi: 10.1038/77558. Nat Med. 2000. PMID: 10888934

7

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, Lichty BD, Brown EG, Sonenberg N, Bell JC. Stojdl DF, et al. Among authors: bell jc. J Virol. 2000 Oct;74(20):9580-5. doi: 10.1128/jvi.74.20.9580-9585.2000. J Virol. 2000. PMID: 11000229 Free PMC article.

8

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. Stojdl DF, et al. Among authors: bell jc. Cancer Cell. 2003 Oct;4(4):263-75. doi: 10.1016/s1535-6108(03)00241-1. Cancer Cell. 2003. PMID: 14585354 Free article.

9

Recent progress in the battle between oncolytic viruses and tumours.

Parato KA, Senger D, Forsyth PA, Bell JC. Parato KA, et al. Among authors: bell jc. Nat Rev Cancer. 2005 Dec;5(12):965-76. doi: 10.1038/nrc1750. Nat Rev Cancer. 2005. PMID: 16294217 Review.

10

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

Power AT, Wang J, Falls TJ, Paterson JM, Parato KA, Lichty BD, Stojdl DF, Forsyth PA, Atkins H, Bell JC. Power AT, et al. Among authors: bell jc. Mol Ther. 2007 Jan;15(1):123-30. doi: 10.1038/sj.mt.6300039. Mol Ther. 2007. PMID: 17164783 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters